Prominin-1 (CD133) expression in the prostate and prostate cancer: A marker for quiescent stem cells

Advances in Experimental Medicine and Biology

Volumn 777, Issue , 2013, Pages 167-184

  Pellacani, Davide ^a   Oldridge, Emma E ^a   Collins, Anne T ^a   Maitland, Norman J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

AC133; Cancer stem cells; CD133; Prominin 1; Prostate; Prostate cancer; Stem cells

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTIANDROGEN; CD133 ANTIGEN; CELL MARKER; CYTOKERATIN 8; HISTONE DEACETYLASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR NANOG; BIOLOGICAL MARKER;

ABLATION THERAPY; ADVANCED CANCER; ANDROGEN THERAPY; ANTIANDROGEN THERAPY; ARTICLE; CANCER LOCALIZATION; CANCER STEM CELL; CASTRATION RESISTANT PROSTATE CANCER; CELL ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL LEVEL; CELL PROLIFERATION; CELL SURVIVAL; CYTOARCHITECTURE; GENE; GENE FUSION; GENOMIC INSTABILITY; HISTOLOGY; HUMAN; LIFE EXPECTANCY; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROM1 GENE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TUMOR BIOPSY; MALE; METABOLISM; PROSTATE TUMOR;

BIOMARKERS; HUMANS; MALE; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS;

EID: 84934436921     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5894-4_11     Document Type: Article

References (108)

1. Kumar VL, Majumder PK (1995) Prostate gland: structure, functions and regulation. Int Urol Nephrol 27:231-243
2. Kyprianou N, Isaacs JT (1988) Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562
3. Sar M, Lubahn DB, French FS, Wilson EM (1990) Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 127:3180-3186
4. Bonkhoff H, Remberger K (1993) Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Archiv 422:35-38
5. Bonkhoff H, Stein U, Remberger K (1995) Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol 26:167-170
6. Rumpold H, Heinrich E, Untergasser G, Hermann M, P fi ster G, Plas E et al (2002) Neuroendocrine differentiation of human prostatic primary epithelial cells in vitro. Prostate 53:101-108
7. Bostwick DG (1996) Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. Eur Urol 30:145-152
8. Grisanzio C, Signoretti S (2008) p63 in prostate biology and pathology. J Cell Biochem 103:1354-1368
9. De Marzo AM, Meeker AK, Epstein JI, Coffey DS (1998) Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol 153:911-919
10. Gleason DF (1966) Classi fication of prostatic carcinomas. Cancer Chemother Rep 50:125-128
11. Bostwick DG (1994) Grading prostate cancer. Am J Clin Pathol 102:S38-S56
12. Hammad FT (2008) Radical prostatectomy. Ann N Y Acad Sci 1138:267-277
13. Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA, Celniker A (1987) Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 47:281-286
14. Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45
15. Yap TA, Zivi A, Omlin A, De Bono JS (2011) The changing therapeutic landscape of castration- resistant prostate cancer. Nat Rev Clin Oncol 8:597-610
16. Oldridge EE, Pellacani D, Collins AT, Maitland NJ (2012) Prostate cancer stem cells: Are they androgen-responsive? Mol Cell Endocrinol 360:14-24
17. Isaacs JT, Coffey DS (1989) Etiology and disease process of benign prostatic hyperplasia. Prostate 2:33-50
18. English HF, Santen RJ, Isaacs JT (1987) Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11:229-242
19. Evans GS, Chandler JA (1987) Cell proliferation studies in the rat prostate: II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation. Prostate 11:339-351
20. Hudson DL, Guy AT, Fry P, O'Hare MJ, Watt FM, Masters JR (2001) Epithelial cell differentiation pathways in the human prostate: identi fication of intermediate phenotypes by keratin expression. J Histochem Cytochem 49:271-278
21. Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA (1992) Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 52:6182-6187
22. Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM, Schalken JA (1988) Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 13:25-38
23. Blackwood JK, Williamson SC, Greaves LC, Wilson L, Rigas AC, Sandher R et al (2011) In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells. J Pathol 225:181-188
24. Gaisa NT, Graham TA, McDonald SA, Poulsom R, Heidenreich A, Jakse G et al (2011) Clonal architecture of human prostatic epithelium in benign and malignant conditions. J Pathol 225:172-180
25. Collins AT, Habib FK, Maitland NJ, Neal DE (2001) Identi fication and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)- integrin expression. J Cell Sci 114:3865-3872
26. Burger PE, Gupta R, Xiong X, Ontiveros CS, Salm SN, Moscatelli D et al (2009) High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells 27:2220-2228
27. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117:3539-3545
28. Frame FM, Hager S, Pellacani D, Stower MJ, Walker HF, Burns JE et al (2010) Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells. Exp Cell Res 316:3161-3171
29. Schmelz M, Moll R, Hesse U, Prasad AR, Gandol fi JA, Hasan SR et al (2005) Identi fication of a stem cell candidate in the normal human prostate gland. Eur J Cell Biol 84:341-354
30. Burger PE, Xiong X, Coetzee S, Salm SN, Moscatelli D, Goto K et al (2005) Sca-1 expression identi fi es stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci USA 102:7180-7185
31. Leong KG, Wang B-E, Johnson L, Gao W-Q (2008) Generation of a prostate from a single adult stem cell. Nature 456:804-808
32. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV et al (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461:495-500
33. Choi N, Zhang B, Zhang L, Ittmann M, Xin L (2012) Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 21:253-265
34. Shen MM, Wang X, Economides KD, Walker D, Abate-Shen C (2008) Progenitor cells for the prostate epithelium: roles in development, regeneration, and cancer. Cold Spring Harb Symp Quant Biol 73:529-538
35. Taylor RA, Toivanen R, Risbridger GP (2010) Stem cells in prostate cancer: treating the root of the problem. Endocr Relat Cancer 17:R273-R285
36. Maitland NJ, Frame FM, Polson ES, Lewis JL, Collins AT (2011) Prostate cancer stem cells: do they have a basal or luminal phenotype? Horm Cancer 2:47-61
37. Googe PB, McGinley KM, Fitzgibbon JF (1997) Anticytokeratin antibody 34 beta E12 staining in prostate carcinoma. Am J Clin Pathol 107:219-223
38. van Leenders GJ, Aalders TW, Hulsbergen-van de Kaa CA, Ruiter DJ, Schalken JA (2001) Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol 195:563-570
39. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730-737
40. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645-648
41. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identi fication of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988
42. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al (2004) Identi fication of human brain tumour initiating cells. Nature 432:396-401
43. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al (2007) Identi fication and expansion of human colon-cancer-initiating cells. Nature 445:111-115
44. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V et al (2007) Identi fication of pancreatic cancer stem cells. Cancer Res 67:1030-1037
45. Ma S, Chan K-W, Hu L, Lee TK-W, Wo JY-H, Ng IO-L et al (2007) Identi fication and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132:2542-2556
46. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A et al (2008) Identi fication and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504-514
47. Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG et al (2009) Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res 15:4299-4311
48. Ma X, Ziel-van der Made AC, Autar B, van der Korput HA, Vermeij M, van Duijn P et al (2005) Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res 65:5730-5739
49. Germann M, Wetterwald A, Guzmán-Ramírez N, van der Pluijm G, Culig Z, Cecchini MG et al (2012) Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer. Stem Cells 30:1076-1086
50. Maitland NJ, Collins AT (2008) In flammation as the primary aetiological agent of human prostate cancer: a stem cell connection? J Cell Biochem 105:931-939
51. Craft N, Chhor C, Tran C, Belldegrun A, DeKernion J, Witte ON et al (1999) Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res 59:5030-5036
52. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identi fication of tumorigenic prostate cancer stem cells. Cancer Res 65:10946-10951
53. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S et al (2006) Highly puri fi ed CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25:1696-1708
54. Brown MD, Gilmore PE, Hart CA, Samuel JD, Ramani VAC, George NJ et al (2007) Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate 67:1384-1396
55. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON (2010) Identi fication of a cell of origin for human prostate cancer. Science 329:568-571
56. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON (2010) Basal epithelial stem cells are Efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA 107:2610-2615
57. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H (2006) Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA 103:1480-1485
58. Liao C-P, Adisetiyo H, Liang M, Roy-Burman P (2010) Cancer-associated fi broblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Res 70:7294-7303
59. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI (2011) Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF- k B signalling. Nat Commun 2:162
60. Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH et al (2008) Gene expression pro fi ling of human prostate cancer stem cells reveals a pro-in fl ammatory phenotype and the importance of extracellular matrix interactions. Genome Biol 9:R83
61. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J et al (2011) Distinct stem cells contribute to mammary gland development and maintenance. Nature 479:189-193
62. Lang SH, Frame FM, Collins AT (2009) Prostate cancer stem cells. J Pathol 217:299-306
63. Jászai J, Fargeas CA, Florek M, Huttner WB, Corbeil D (2007) Focus on molecules: prominin- 1 (CD133). Exp Eye Res 85:585-586
64. Mizrak D, Brittan M, Alison MR (2008) CD133: molecule of the moment. J Pathol 214:3-9
65. Missol-Kolka E, Karbanová J, Janich P, Haase M, Fargeas CA, Huttner WB et al (2011) Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate. Prostate 71:254-267
66. Campos B, Herold-Mende CC (2011) Insight into the complex regulation of CD133 in glioma. Int J Cancer 128:501-510
67. Kemper K, Sprick MR, de Bree M, Scopelliti A, Vermeulen L, Hoek M et al (2010) The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 70:719-729
68. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT et al (1997) A novel fi vetransmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90:5013-5021
69. Mak AB, Blakely KM, Williams RA, Penttila P-A, Shukalyuk AI, Osman KT et al (2011) CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. J Biol Chem 286:41046-41056
70. Karbanová J, Missol-Kolka E, Fonseca A-V, Lorra C, Janich P, Hollerová H et al (2008) The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 56:977-993
71. Bidlingmaier S, Zhu X, Liu B (2008) The utility and limitations of glycosylated human CD133 epitopes in de fi ning cancer stem cells. J Mol Med 86:1025-1032
72. Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S et al (2007) Identi fication of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67:3153-3161
73. Eaton CL, Colombel M, van der Pluijm G, Cecchini MG, Wetterwald A, Lippitt J et al (2010) Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer. Prostate 70:875-882
74. Shmelkov SV, St Clair R, Lyden D, Rafii S (2005) AC133/CD133/Prominin-1. Int J Biochem Cell Biol 37:715-719
75. Fargeas CA, Huttner WB, Corbeil D (2007) Nomenclature of prominin-1 (CD133) splice variants - an update. Tissue Antig 69:602-606
76. Pellacani D, Packer RJ, Frame FM, Oldridge EE, Berry PA, Labarthe M-C et al (2011) Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer. Mol Cancer 10:94
77. Shepherd CJ, Rizzo S, Ledaki I, Davies M, Brewer D, Attard G et al (2008) Expression pro fi ling of CD133+ and CD133- epithelial cells from human prostate. Prostate 68:1007-1024
78. Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA, Usenko JK et al (2004) Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 103:2055-2061
79. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD et al (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28:3949-3959
80. Iida H, Suzuki M, Goitsuka R, Ueno H (2012) Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2. Int J Oncol 40:71-79
81. Matsumoto K, Arao T, Tanaka K, Kaneda H, Kudo K, Fujita Y et al (2009) mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res 69:7160-7164
82. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T et al (2011) Prostate cancer cell lines under hypoxia exhibit greater stem-like properties. PLoS One 6:e29170
83. Yeung TM, Gandhi SC, Bodmer WF (2011) Hypoxia and lineage speci fication of cell linederived colorectal cancer stem cells. Proc Natl Acad Sci USA 108:4382-4387
84. Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CMA et al (2011) HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells. Cancer Res 71:4640-4652
85. Bar EE (2011) Glioblastoma, cancer stem cells and hypoxia. Brain Pathol 21:119-129
86. Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG (2010) Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177:1491-1502
87. Tabu K, Kimura T, Sasai K, Wang L, Bizen N, Nishihara H et al (2010) Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stemlike hallmarks. Mol Cancer 9:39
88. You H, Ding W, Rountree CB (2010) Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta. Hepatology 51:1635-1644
89. Mak AB, Nixon AML, Moffat J (2012) The mixed lineage leukemia (MLL) fusion-associated gene AF4 promotes CD133 transcription. Cancer Res 72:1929-1934
90. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T et al (2009) Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 28:209-218
91. Pleshkan VV, Vinogradova TV, Sverdlov ED (2008) Methylation of the prominin 1 TATAless main promoters and tissue specificity of their transcript content. Biochim Biophys Acta 1779:599-605
92. Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E, Kohsaka S et al (2008) Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res 18:1037-1046
93. Yi JM, Tsai H-C, Glöckner SC, Lin S, Ohm JE, Easwaran H et al (2008) Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 68:8094-8103
94. Yu Y, Flint A, Dvorin EL, Bischoff J (2002) AC133-2, a novel isoform of human AC133 stem cell antigen. J Biol Chem 277:20711-20716
95. Zhou J, Wang H, Cannon V, Wolcott KM, Song H, Yates C (2011) Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells. Mol Cancer 10:112
96. Wei C, Guomin W, Yujun L, Ruizhe Q (2007) Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Cancer Biol Ther 6:763-768
97. Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira S-M, García-Echeverría C et al (2009) The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 106:268-273
98. Marian CO, Wright WE, Shay JW (2010) The effects of telomerase inhibition on prostate tumor-initiating cells. Int J Cancer 127:321-331
99. Pfeiffer MJ, Schalken JA (2010) Stem cell characteristics in prostate cancer cell lines. Eur Urol 57:246-254
100. Chunthapong J, Seftor EA, Khalkhali-Ellis Z, Seftor REB, Amir S, Lubaroff DM et al (2004) Dual roles of E-cadherin in prostate cancer invasion. J Cell Biochem 91:649-661
101. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, De Marzo AM, Isaacs JT (2008) The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 68:9703-9711
102. Lang SH, Anderson E, Fordham R, Collins AT (2010) Modeling the prostate stem cell niche: an evaluation of stem cell survival and expansion in vitro. Stem Cells Dev 19:537-546
103. Taylor RA, Toivanen R, Frydenberg M, Pedersen J, Harewood L, Australian Prostate Cancer Bioresource et al (2012) Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. Stem Cells 30:1087-1096
104. Corbeil D, Röper K, Fargeas CA, Joester A, Huttner WB (2001) Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2:82-91
105. Bauer N, Fonseca A-V, Florek M, Freund D, Jászai J, Bornhäuser M et al (2008) New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs 188:127-138
106. Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC (2010) Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci USA 107:2195-2200
107. Takenobu H, Shimozato O, Nakamura T, Ochiai H, Yamaguchi Y, Ohira M et al (2010) CD133 suppresses neuroblastoma cell differentiation via signal pathway modi fication. Oncogene 30:95-105
108. Tost J, Gut IG (2007) DNA methylation analysis by pyrosequencing. Nat Protoc 2:2265-2275